tiprankstipranks
Advertisement
Advertisement
Rallybio, Candid Therapeutics announce merger agreement
PremiumThe FlyRallybio, Candid Therapeutics announce merger agreement
1M ago
Rallybio’s RLYB116 Clears Phase 1 Milestone, Sharpening Its Autoimmune Pipeline
Premium
Company Announcements
Rallybio’s RLYB116 Clears Phase 1 Milestone, Sharpening Its Autoimmune Pipeline
1M ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/16/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/16/26
1M ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/9/26
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—2/9/26
2M ago
Rallybio Corp trading halted, news pending
Premium
The Fly
Rallybio Corp trading halted, news pending
2M ago
Rallybio announces reverse 1-for-8 stock split
Premium
The Fly
Rallybio announces reverse 1-for-8 stock split
2M ago
Rallybio Corporation Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsRallybio Corporation Reports Strong Q3 2025 Results
5M ago
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment
Premium
Company Announcements
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment
5M ago
Rallybio completes dosing of first cohort in RLYB116 study
Premium
The Fly
Rallybio completes dosing of first cohort in RLYB116 study
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100